Gujarat Themis Biosyn Ltd. moves to reshape its capital structure

The QIP expands Gujarat Themis Biosyn’s share base by 19.45%, taking paid-up equity shares from 10.90 crore to 13.02 crore. On a post-issue basis, the new shares represent 16.27% of the enlarged equity base; an existing shareholder who did not participate would therefore see their proportional ownership reduced by approximately 16.27%.

Equity-base impact

• Pre-issue: 10,89,65,265 equity shares of face value Rs 1 each ^[1]
• QIP allotment: 2,11,86,440 shares at Rs 354 per share, raising Rs 750 crore gross ^[1]
• Post-issue: 13,01,51,705 equity shares ^[1]
• Derived increase in share count: 2,11,86,440 / 10,89,65,265 = 19.45%
• Derived post-issue ownership of QIP investors: 2,11,86,440 / 13,01,51,705 = 16.27%
• Paid-up share capital: increases from approximately Rs 10.90 crore to Rs 13.02 crore. The balance of the gross issue proceeds, approximately Rs 747.88 crore, represents the issue premium, before issue expenses; this is derived from the Rs 1 face value and Rs 353 premium per share ^[1].

Utilization versus capex and working capital

The allotment filing confirms the Rs 750 crore fund raise, but does not provide a capex-versus-working-capital allocation, named projects, implementation timelines, or the amount earmarked for general corporate purposes ^[1]. News coverage characterizes the proceeds only broadly as supporting business objectives and growth plans ^[2].

Accordingly, the strategic alignment cannot be established quantitatively from the cited disclosures. The relevant test is whether the QIP placement document specifies:

• funding for identified capacity expansion or other capital expenditure;
• the timing and size of those investments;
• an explicit allocation to inventory, receivables or other working-capital needs; and
• any residual amount for general corporate purposes or debt reduction.

Analytical implication: the equity-base effect is clear and immediately dilutive to existing holders, while the economic justification depends on whether the placement document links the Rs 750 crore to identifiable capex or a documented working-capital requirement. Until that allocation is disclosed, the raise can be described as balance-sheet strengthening and growth funding, but not as demonstrably matched to a quantified capital requirement.

The final QIP issue price was Rs 354 per share. This was Rs 18.57 below the SEBI-calculated floor price, representing a 4.98% discount to the floor price. The implied floor price was therefore approximately Rs 372.57 per share (Rs 354 + Rs 18.57). ^[1]

The filing does not report the company’s VWAP for the period immediately preceding the 28 August 2026 allotment, so the issue price cannot be quantitatively compared with that VWAP from the cited disclosure. The confirmed comparison is:

Notes: †Derived from the disclosed issue price and stated discount amount; the filing directly states the 4.98% discount.

The QIP materially dilutes promoter ownership on a percentage basis, while sharply lowering pro-forma leverage. The company allotted 2.12 Crore shares to QIBs at Rs 354 per share, raising approximately Rs 750 Crores ^[3].

Post-issue shareholding

Using the latest reported equity share capital of Rs 10.90 Crores at a Rs 1 face value, the pre-issue share count is approximately 10.90 Crore shares ^{[4] [5]}. After the 2.12 Crore-share allotment, the estimated post-issue share count becomes approximately 13.02 Crore.

Notes: † Derived from 10.90 Crore existing shares ^[4], 2.12 Crore allotted shares ^[3], and the reported 70.86% promoter holding ^[6]. Assumes no promoter participation in the QIP and no change in existing promoter share count.

Thus, promoter ownership would fall from 70.86% to approximately 59.33%, a relative dilution of about 16.27%. Promoters would retain the same number of shares under this assumption; the dilution arises because the denominator increases.

The reported shareholding data also lists “promoter shares” at 68.49%, separate from “promoter holdings” of 70.86% ^[6]. If 68.49% is the intended pre-issue base, the corresponding post-issue promoter holding would be approximately 57.34%, down 11.15 pp. The company’s post-allotment filing will be needed to resolve this classification difference and confirm the final promoter percentage.

Debt-to-equity impact

The latest standalone balance-sheet figures show total debt of Rs 159.86 Crores and total equity of Rs 287.76 Crores ^{[7] [8]}. This corresponds to the reported debt-to-equity ratio of 0.56x ^[9].

Assuming the full Rs 750 Crore gross proceeds are added to equity through share capital and securities premium, with no issue-cost adjustment and no immediate debt repayment:

• Pro-forma equity = Rs 287.76 Crores + Rs 750 Crores = Rs 1,037.76 Crores
• Pro-forma debt-to-equity = Rs 159.86 Crores / Rs 1,037.76 Crores = 0.15x†
• Reduction = 0.41x, or approximately 72.5%† from 0.56x

This is a mechanical pro-forma calculation, not a post-issue reported balance-sheet ratio. Actual leverage could be lower if part of the proceeds repays debt, while the ratio would remain broadly similar if the funds are retained or deployed into acquisitions and capex without additional borrowing.